• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    38 Stocks Moving In Wednesday's Mid-Day Session

    4/27/22 12:09:08 PM ET
    $AFIB
    $AGRX
    $ALKS
    $BILI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AFIB alert in real time by email

     

    Gainers

    • Vivakor, Inc. (NASDAQ:VIVK) gained 154% to $4.3550 after the company announced it has signed a 10-year contract with Hot Oil Transport with a potential value of up to $250 million.
    • Cosmos Holdings Inc. (NASDAQ:COSM) shares jumped 76.5% to $1.8710 after jumping over 16% on Tuesday. Cosmos Holdings recently posted FY21 adjusted net income of $384K.
    • Acutus Medical, Inc. (NASDAQ:AFIB) climbed 31% to $1.0500 after the company announced agreements to fund strategic growth priorities.
    • Nutex Health, Inc. (NASDAQ:NUTX) gained 25.6% to $9.65 after jumping 74% on Tuesday.
    • Tempest Therapeutics, Inc. (NASDAQ:TPST) jumped 20% to $2.84. Tempest reported a $15 million private placement financing.
    • Repligen Corporation (NASDAQ:RGEN) shares climbed 15.8% to $165.01 after reporting upbeat Q1 results.
    • Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) jumped 14.4% to $25.00. Pfizer agreed to invest $25 million in Zentalis Pharmaceuticals via the purchase of 953,834 shares at $26.21 per share.
    • Alkermes plc (NASDAQ:ALKS) gained 14.1% to $30.96 following better-than-expected Q1 results.
    • TradeUP Global Corporation (NASDAQ:TUGC) gained 13.9% to $10.48.
    • Enphase Energy, Inc. (NASDAQ:ENPH) rose 13.4% to $174.50 after the company reported better-than-expected Q1 adjusted EPS and sales results and issued Q2 sales guidance above analyst estimates.
    • Mattel, Inc. (NASDAQ:MAT) rose 12.1% to $24.77 following a WSJ report suggesting the company is in talks with private-equity firms about a potential sale.
    • Digital World Acquisition Corp. (NASDAQ:DWAC) gained 11.3% to $45.45.
    • Vertiv Holdings Co (NYSE:VRT) gained 10.6% to $12.76 following upbeat Q1 results.
    • JinkoSolar Holding Co., Ltd. (NYSE:JKS) jumped 10.3% to $55.38.
    • Nordic American Tankers Limited (NYSE:NAT) gained 9.6% to $2.7950.
    • Bilibili Inc. (NASDAQ:BILI) surged 9.4% to $22.51.
    • Visa Inc. (NYSE:V) rose 8.7% to $218.64 following upbeat quarterly earnings.
    • Microsoft Corporation (NASDAQ:MSFT) rose 4.5% to $282.45 as the company reported better-than-expected results for its third quarter.

     

    Losers

    • Molecular Partners AG (NASDAQ:MOLN) shares dipped 37.6% to $8.60. The company’s collaborating partner Amgen for MP0310 (AMG 506) will return the global rights of MP0310 to Molecular Partners following a strategic pipeline review.
    • Agile Therapeutics, Inc. (NASDAQ:AGRX) fell 31.4% to $3.07 following effectiveness of 1:40 reverse stock split.
    • NCR Corporation (NYSE:NCR) fell 22.9% to $28.78 after the company reported worse-than-expected Q1 EPS and sales results. The company also cut its FY22 EPS and sales guidance.
    • Extreme Networks, Inc. (NASDAQ:EXTR) dipped 15.6% to $9.53 following Q3 results.
    • Immunome, Inc. (NASDAQ:IMNM) dropped 15% to $3.1256.
    • Silence Therapeutics plc (NASDAQ:SLN) fell 14.4% to $12.40.
    • Forge Global Holdings, Inc. (NYSE:FRGE) declined 14.1% to $15.86.
    • JE Cleantech Holdings Limited (NASDAQ:JCSE) dropped 13.5% to $14.01.
    • Sono Group N.V. (NASDAQ:SEV) fell 13.5% to $5.11 after the company reported a 10 million share follow-on offering.
    • Evoke Pharma, Inc. (NASDAQ:EVOK) fell 13.1% to $0.7476. Evoke Pharma shares jumped over 118% on Tuesday as the FDA granted new drug product exclusivity to Evoke Pharma's Gimoti (metoclopramide) nasal spray to relieve symptoms associated with acute and recurrent diabetic gastroparesis in adults.
    • F5, Inc. (NASDAQ:FFIV) fell 12.4% to $169.90 after the company reported Q2 earnings results and issued Q3 sales guidance below analyst estimates.
    • Blackboxstocks Inc. (NASDAQ:BLBX) declined 10.6% to $4.30.
    • Hawaiian Holdings, Inc. (NASDAQ:HA) dropped 10.6% to $16.59 following Q1 results.
    • Spotify Technology S.A. (NYSE:SPOT) dipped 10.1% to $99.24 after the company reported Q1 financial results.
    • Trinity Industries, Inc. (NYSE:TRN) fell 10% to $27.56 following downbeat quarterly results.
    • Diebold Nixdorf, Incorporated (NYSE:DBD) dropped 10% to $4.25.
    • Q&K International Group Limited (NASDAQ:QK) shares fell 9.3% to $1.0701 after jumping around 19% on Tuesday.
    • Deutsche Bank Aktiengesellschaft (NYSE:DB) shares fell 7.6% to $10.05 following Q1 earnings.
    • Capital One Financial Corporation (NYSE:COF) declined 6.6% to $123.53 after the company reported Q1 earnings results.
    • Alphabet Inc. (NASDAQ:GOOGL) fell 4.5% to $2,266.53 following downbeat quarterly earnings.

     

    Get the next $AFIB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AFIB
    $AGRX
    $ALKS
    $BILI

    CompanyDatePrice TargetRatingAnalyst
    Visa Inc.
    $V
    4/22/2026$365.00Outperform
    BMO Capital Markets
    Nordic American Tankers Limited
    $NAT
    4/22/2026$4.50In-line → Underperform
    Evercore ISI
    Microsoft Corporation
    $MSFT
    4/21/2026$635.00 → $600.00Buy
    Citigroup
    Alphabet Inc.
    $GOOGL
    4/20/2026$370.00 → $380.00Overweight
    KeyBanc Capital Markets
    Deutsche Bank AG
    $DB
    4/20/2026Overweight → Equal Weight
    Barclays
    Repligen Corporation
    $RGEN
    4/17/2026$160.00Buy
    Rothschild & Co Redburn
    Microsoft Corporation
    $MSFT
    4/15/2026$540.00 → $500.00Outperform
    Robert W. Baird
    Microsoft Corporation
    $MSFT
    4/14/2026$620.00 → $515.00Outperform
    Mizuho
    More analyst ratings

    $AFIB
    $AGRX
    $ALKS
    $BILI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Legal Officer-Healthcare Montgomery Pamela W. bought $7,021 worth of shares (79 units at $88.87), increasing direct ownership by 3% to 2,758 units (SEC Form 4)

    4 - Nutex Health Inc. (0001479681) (Issuer)

    3/16/26 3:02:43 PM ET
    $NUTX
    Real Estate

    Director Bienaime Jean Jacques bought $43,670 worth of shares (2,000 units at $21.84), increasing direct ownership by 5% to 38,415 units (SEC Form 4)

    4 - Immunome Inc. (0001472012) (Issuer)

    3/12/26 6:05:05 AM ET
    $IMNM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Stanton John W bought $1,986,750 worth of shares (5,000 units at $397.35), increasing direct ownership by 6% to 83,905 units (SEC Form 4)

    4 - MICROSOFT CORP (0000789019) (Issuer)

    2/18/26 6:14:22 PM ET
    $MSFT
    Computer Software: Prepackaged Software
    Technology

    $AFIB
    $AGRX
    $ALKS
    $BILI
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for GIMOTI

    Submission status for EVOKE PHARMA INC's drug GIMOTI (SUPPL-1) with active ingredient METOCLOPRAMIDE HYDROCHLORIDE has changed to 'Approval' on 01/14/2021. Application Category: NDA, Application Number: 209388, Application Classification: Labeling

    1/15/21 5:10:35 AM ET
    $EVOK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AFIB
    $AGRX
    $ALKS
    $BILI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BMO Capital Markets initiated coverage on Visa with a new price target

    BMO Capital Markets initiated coverage of Visa with a rating of Outperform and set a new price target of $365.00

    4/22/26 7:58:45 AM ET
    $V
    Real Estate

    Nordic American Tanker downgraded by Evercore ISI with a new price target

    Evercore ISI downgraded Nordic American Tanker from In-line to Underperform and set a new price target of $4.50

    4/22/26 7:53:45 AM ET
    $NAT
    Marine Transportation
    Consumer Discretionary

    Citigroup reiterated coverage on Microsoft with a new price target

    Citigroup reiterated coverage of Microsoft with a rating of Buy and set a new price target of $600.00 from $635.00 previously

    4/21/26 6:45:24 AM ET
    $MSFT
    Computer Software: Prepackaged Software
    Technology

    $AFIB
    $AGRX
    $ALKS
    $BILI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Deutsche Bank Appointed as Depositary Bank for the Sponsored American Depositary Receipt Program of American Tungsten & Antimony Limited

    Deutsche Bank announced today its appointment as depositary bank for the American Depositary Receipt program of American Tungsten & Antimony Limited. American Tungsten & Antimony Limited (OTC:ATAYY) is an ASX-listed critical minerals company ((ASX: AT4, OTCQB:ATALF) focused on the exploration and development of antimony and tungsten projects in the United States. The company's portfolio includes the flagship Antimony Canyon Project in Utah, together with a portfolio of tungsten projects across Utah and Nevada including Tennessee Mountain, Fraction Lode, Nightingale and Dutch Mountain. The company is pursuing a U.S.-based hub-and-spoke processing and refining strategy aligned with U.S. Gov

    4/23/26 4:05:00 PM ET
    $DB
    Major Banks
    Finance

    Diebold Nixdorf Achieves Stable 'BB-' Rating from Fitch

    NORTH CANTON, Ohio, April 23, 2026 /PRNewswire/ -- Diebold Nixdorf (NYSE:DBD), a world leader in transforming the way people bank and shop, today announced Fitch Ratings, Inc. ("Fitch") has assigned the company a first-time Long-Term Issuer Default Rating of 'BB-' with a stable outlook. Tom Timko, Diebold Nixdorf executive vice president and chief financial officer, said: "Receiving a 'BB-' rating from Fitch is another significant milestone for our company and an additional validation of our operational execution, fortress balance sheet and consistent free cash flow generation.

    4/23/26 4:02:00 PM ET
    $DBD
    Office Equipment/Supplies/Services
    Miscellaneous

    Nutex Health Schedules 2026 First Quarter Financial Results Release and Conference Call

    HOUSTON, April 22, 2026 /PRNewswire/ -- Nutex Health, Inc. (NASDAQ:NUTX), a physician-led, integrated healthcare delivery system comprised of 27 state-of-the-art micro hospitals and hospital outpatient departments in 12 states and primary care-centric, risk-bearing physician networks, today announced that it plans to file its Form 10-Q for the first fiscal quarter ended March 31, 2026, on Thursday, April 30, 2026 after the market close. The Company will also issue a corresponding press release summarizing financial results on the same day. Nutex Health will host its earnings conference call on Friday, May 1, 2026, at 9:30 a.m. CT to discuss the Company's financial performance and provide a b

    4/22/26 4:15:00 PM ET
    $NUTX
    Real Estate

    $AFIB
    $AGRX
    $ALKS
    $BILI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Kelly James Jim

    3 - NORDIC AMERICAN TANKERS Ltd (0001000177) (Issuer)

    4/23/26 8:39:48 AM ET
    $NAT
    Marine Transportation
    Consumer Discretionary

    SEC Form 4 filed by Loeillot Olivier

    4 - REPLIGEN CORP (0000730272) (Issuer)

    4/22/26 1:26:04 PM ET
    $RGEN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 4 filed by Johnson Michael Edious

    4 - Aptera Motors Corp (0001786471) (Issuer)

    4/21/26 2:28:38 PM ET
    $SEV
    Auto Manufacturing
    Industrials

    $AFIB
    $AGRX
    $ALKS
    $BILI
    SEC Filings

    View All

    SEC Form DEFA14A filed by Vertiv Holdings LLC

    DEFA14A - Vertiv Holdings Co (0001674101) (Filer)

    4/24/26 6:35:10 AM ET
    $VRT
    Industrial Machinery/Components
    Technology

    SEC Form DEF 14A filed by Vertiv Holdings LLC

    DEF 14A - Vertiv Holdings Co (0001674101) (Filer)

    4/24/26 6:30:31 AM ET
    $VRT
    Industrial Machinery/Components
    Technology

    Nutex Health Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - Nutex Health Inc. (0001479681) (Filer)

    4/23/26 4:05:58 PM ET
    $NUTX
    Real Estate

    $AFIB
    $AGRX
    $ALKS
    $BILI
    Leadership Updates

    Live Leadership Updates

    View All

    Visa Launches Validator Node on Tempo Blockchain

    Visa has joined the Tempo network as an anchor validator, supporting transaction validation and accelerating the development of onchain payment infrastructure. Visa (NYSE:V), a global leader in digital payments, today announced it has officially launched its validator node on the Tempo network, marking a key milestone in Visa's continued advancement of blockchain infrastructure leadership and its role in shaping stablecoin payments. The launch underscores Visa's commitment to running critical blockchain operations in-house and strengthening the foundations of onchain payment innovation. Tempo, the next generation blockchain built for agentic commerce and real-time payments, has expanded

    4/14/26 9:06:00 AM ET
    $V
    Real Estate

    Tempest Appoints Andrew Fang, Ph.D., as Head of Business Development to Advance Strategic Partnerships and Global Licensing Efforts

    Adds dedicated business development leadership to support Tempest's strategic prioritiesWill lead China outreach and cross-border partnership effortsTo support ongoing partnering discussions for Phase 3-ready amezalpat program, including potential China development opportunities BRISBANE, Calif., April 14, 2026 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (NASDAQ:TPST) ("Tempest"), a clinical-stage biotechnology company developing a pipeline of advanced CAR-T cell therapy product candidates to treat cancer, today announced the appointment of Andrew Fang, Ph.D., as Head of Business Development. Dr. Fang will lead Tempest's global business development efforts, including strategic partners

    4/14/26 8:00:00 AM ET
    $TPST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Diebold Nixdorf Set to Join S&P SmallCap 600

    NEW YORK, April 7, 2026 /PRNewswire/ -- Diebold Nixdorf Inc. (NYSE:DBD) will replace Sealed Air Corp. (NYSE:SEE) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, April 10. Clayton, Dubilier & Rice LLC is acquiring Sealed Air in a deal expected to be completed April 9. Following is a summary of the changes that will take place prior to the open of trading on the effective date:Effective DateIndex Name       ActionCompany NameTickerGICS SectorApril 10, 2026S&P SmallCap 600AdditionDiebold NixdorfDBDInformation TechnologyApril 10, 2026S&P SmallCap 600DeletionSealed AirSEEMaterialsABOUT S&P DOW JONES INDICESS&P Dow Jones Indices is the largest global resource for essen

    4/7/26 5:47:00 PM ET
    $DBD
    $SEE
    $SPGI
    Office Equipment/Supplies/Services
    Miscellaneous
    Major Chemicals
    Industrials

    $AFIB
    $AGRX
    $ALKS
    $BILI
    Financials

    Live finance-specific insights

    View All

    Nutex Health Schedules 2026 First Quarter Financial Results Release and Conference Call

    HOUSTON, April 22, 2026 /PRNewswire/ -- Nutex Health, Inc. (NASDAQ:NUTX), a physician-led, integrated healthcare delivery system comprised of 27 state-of-the-art micro hospitals and hospital outpatient departments in 12 states and primary care-centric, risk-bearing physician networks, today announced that it plans to file its Form 10-Q for the first fiscal quarter ended March 31, 2026, on Thursday, April 30, 2026 after the market close. The Company will also issue a corresponding press release summarizing financial results on the same day. Nutex Health will host its earnings conference call on Friday, May 1, 2026, at 9:30 a.m. CT to discuss the Company's financial performance and provide a b

    4/22/26 4:15:00 PM ET
    $NUTX
    Real Estate

    Repligen to Report First Quarter 2026 Financial Results

    WALTHAM, Mass., April 22, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its first quarter 2026 financial results on Tuesday, May 5, 2026. The Company will issue a press release before the market opens and will host a conference call at 8:00 a.m. ET to discuss business updates and financial results for the three-month reporting period ended March 31, 2026. The conference call will be accessible by dialing toll-free (833) 461-5787 for domestic callers and (585) 542-9983 for international callers. The meeting ID is: 931163466. In addition, a webcast will be accessible via the Investor Relations section of the Company's website. The w

    4/22/26 7:30:00 AM ET
    $RGEN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Vertiv Reports Strong First Quarter with Diluted EPS Growth of 136% (Adjusted Diluted EPS Growth of +83%); Raises Full-Year Guidance

    First Quarter 2026 ResultsNet sales of $2,650 million, 30% higher than first quarter 2025Operating profit up 51% and adjusted operating profit(1) up 64% from first quarter 2025. Adjusted operating margin of 20.8%, up 430 basis points compared to first quarter 2025Operating cash flow of $767 million and adjusted free cash flow of $653 million, an increase of 153% and 147%, respectively, compared to prior year first quarter. Net leverage of ~0.2x at the end of first quarter 2026Full Year 2026 GuidanceExpect net sales of $13,500 to $14,000 million, with organic sales growth of 29% to 31% compared to 2025Expect full year 2026 diluted EPS of $5.60 to $5.70 and adjusted diluted EPS of $6.30 to $6.

    4/22/26 5:55:00 AM ET
    $VRT
    Industrial Machinery/Components
    Technology

    $AFIB
    $AGRX
    $ALKS
    $BILI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Acutus Medical Inc.

    SC 13D/A - Acutus Medical, Inc. (0001522860) (Subject)

    12/16/24 9:52:56 PM ET
    $AFIB
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Amendment: SEC Form SC 13G/A filed by Immunome Inc.

    SC 13G/A - Immunome Inc. (0001472012) (Subject)

    11/14/24 9:00:58 PM ET
    $IMNM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Cosmos Health Inc.

    SC 13G/A - Cosmos Health Inc. (0001474167) (Subject)

    11/14/24 4:50:24 PM ET
    $COSM
    Other Pharmaceuticals
    Health Care